MSPEA Launches $147M Share Sale Of Sihuan Pharma

Investment Research Team
April 3, 2014 — 11:55 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: china pharma exits healthcare Hong Kong IPO medicine Morgan Stanley Morgan Stanley Private Equity Asia MSPEA pharmaceutical Private Equity singapore

Related News:

Chinese Electric Vehicles Expand Global Reach, Export Growth Surges by 84% Outside China

December 19, 2023 — 00:50

China To Expand Investment Scope for Its National Social Security Fund

December 8, 2023 — 00:03

US’s Top 10 Public Companies Worth Over Five Times Than China’s Top 10

December 21, 2021 — 23:37

China Tech Digest: Luckin Coffee Files For Bankruptcy In New York

February 6, 2021 — 07:36

Pandemic Pushes China’s Sports Tech To New Heights And New Models

February 6, 2021 — 05:23

China Tech Digest: SMIC To Expand Production Of 12-Inch Lines

February 5, 2021 — 00:41

DealShot: 19 Deals Passing $780 Million Involving Trustbridge Partners, Sequoia And More

December 28, 2020 — 15:03

China Tech Digest: Baidu, New Oriental Seeks Second Listing In Hong Kong, China 5G Leads With 110M Users

October 23, 2020 — 01:33

What Does SARS Show About Chinese Tech Investments During COVID-19?

April 9, 2020 — 02:49

Franchising and Licensing Asia (FLAsia) 2024